Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model.
Harvey, B S
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. [electronic resource] - Cytokine Feb 2014 - 236-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0023
10.1016/j.cyto.2013.10.006 doi
Arachidonic Acids--pharmacology
Blotting, Western
Caco-2 Cells
Cannabidiol--pharmacology
Cell Membrane Permeability--drug effects
Electric Impedance
Endocannabinoids--pharmacology
Epithelial Cells--drug effects
Epithelium--drug effects
Humans
In Vitro Techniques
Interleukin-17--adverse effects
Interleukin-1beta--pharmacology
Intestinal Mucosa--drug effects
Ligands
Matrix Metalloproteinases--metabolism
Models, Biological
Polyunsaturated Alkamides--pharmacology
Tumor Necrosis Factor-alpha--pharmacology
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. [electronic resource] - Cytokine Feb 2014 - 236-44 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1096-0023
10.1016/j.cyto.2013.10.006 doi
Arachidonic Acids--pharmacology
Blotting, Western
Caco-2 Cells
Cannabidiol--pharmacology
Cell Membrane Permeability--drug effects
Electric Impedance
Endocannabinoids--pharmacology
Epithelial Cells--drug effects
Epithelium--drug effects
Humans
In Vitro Techniques
Interleukin-17--adverse effects
Interleukin-1beta--pharmacology
Intestinal Mucosa--drug effects
Ligands
Matrix Metalloproteinases--metabolism
Models, Biological
Polyunsaturated Alkamides--pharmacology
Tumor Necrosis Factor-alpha--pharmacology